Identification and validation of tumor-associated autoantibodies for diagnosis and differential diagnosis of pancreatic intraductal papillary mucinous neoplasms and pancreatic ductal adenocarcinoma

Ähnliche Einträge

• Pancreatic intraductal papillary mucinous neoplasm: where is the challenge?
  von: Fritz, Stefan, et al.
  Veröffentlicht: (2015)
• Blood-based diagnosis and risk stratification of patients with Pancreatic Intraductal Papillary Mucinous Neoplasm (IPMN)
  von: Zhang, Chaoyang, et al.
  Veröffentlicht: (2023)
• Identification of novel serum autoantibodies for differential diagnosis of autoimmune pancreatitis and pancreatic ductal adenocarcinoma
  von: Felix, Klaus M., et al.
  Veröffentlicht: (2016)
• Intraductal papillary mucinous neoplasm: the tip of the iceberg
  von: Fischer, Lars, et al.
  Veröffentlicht: (2011)
• Use of autoreactive antibodies in blood of patients with pancreatic in intraductal papillary mucinous neoplasms (IPMN) for grade distinction and detection of malignancy
  von: Brindl, Niall, et al.
  Veröffentlicht: (2022)